Last $93.27 USD
Change Today 0.00 / 0.00%
Volume 0.0
MDVN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Stuttgart
As of 8:10 PM 09/15/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Pablo D. T. Valenzuela Ph.D.

Member of Scientific & Clinical Advisory Board, Medivation, Inc.
AgeTotal Calculated CompensationThis person is connected to 30 board members in 4 different organizations across 4 different industries.

See Board Relationships
71--

Background*

Dr. Pablo D.T. Valenzuela, Ph.D. is a Founder and President at Bios Chile. He is the Co-founder and Head of Research and Development of Grupo Bios, Austral Biologicals, Andes Bioscience, Ventra Bioscience, Fundación Ciencia Para la Vida, and at Chiron Corporation where he also served as the Senior Vice President, Biological Research and Development until 2000. He serves as a Director of Ventria Bioscience, Inc. Dr. Valenzuela serves as a Member of Scientific & Clinical ...

Read Full Background

Corporate Headquarters*

525 Market Street
San Francisco, California 94105

United States

Phone: 415-543-3470
Fax: 415-543-3411

Board Members Memberships*

Director
President of the Board
1999-Present
Director, Member of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee

Education*

PhD
Northwestern University
Post-Doctoral Training
University of California-San Francisco

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDVN:US $93.27 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics Inc.
$724.4K
Daniel G. Welch Chairman, Chief Executive Officer and President
InterMune, Inc.
$703.4K
Shailesh Ayyangar B.V.Fc & A.H., P.G.D.M.Managing Director, Vice President of South Asia - Global Operations, Executive Director and Member of Audit Committee
Sanofi India Limited
8.6M
Aijaz Tobaccowalla Managing Director, Additional Director and Member of Board Administrative Committee
Pfizer Limited
17.6M
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIVATION INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.